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Dendritic cells have been isolated from the epider­
mis,dermis, and lymphatics of skin. Cells from each 
cutaneous compartment can exhibit the distinct mor­
phology, surface phenotype, and strong T -cell-stim­
ulating activity of dendritic cells that are isolated 
from other organs. Of importance are the mecha­
nisms by which the maturation and movement of 
dendritic cells are regulated within intact tissues. 
Epidermal dendritic cells turn over slowly in the 
steady state. Stimuli, including contact allergens and 
transplantation, perhaps by inducing a release of 
cytokines such as granulocyte macrophage-colony­
stimulating factor, mobilize these dendritic cells into 
the dermis and lymph. This migration is accompa­
nied by the maturation of dendritic cell functions; 
e.g., antigen-presenting major histocompatibility 
complex molecules and B7 costimulators increase 
markedly. On the other hand, there is a sizable, 
steady-state flux of dendritic cells in afferent lymph 
draining the skin, which suggests a constant traffic 
through the dermis that is independent of sessile 
GENERAL FEATURES OF THE DENDRITIC CELL SYSTEM 
Identification The dendritic cells that are isolated from skin are, 
in most respects, similar to counterparts in many other lymphoid 
and nonlymphoid tissues [1,2]. These shared features are summa­
rized in Fig 1. However, skin dendritic cells have been vital for 
identifYing features of development ("maturation") and movement 
in situ ("migration"). 
The distinct morphology of dendritic cells is diagrammed in Fig 
1, i.e., sheet-like processes that are motile and are continually being 
extended and retracted; a vacuolar system, which typically has few 
lysosomes but can have many acidic endocytic vacuoles; and 
irregularly shaped nuclei. 
Figure 1 (right) shows the features that distinguish dendritic cells 
from lymphocytes and mononuclear phagocytes (blood and inflam­
matory monocytes, resident or tissue macrophages). Dendritic cells 
typically are nonadherent to tissue culture surfaces, are weakly 
phagocytic, and have low levels of Fc and C3 receptors. However, 
skin dendritic cells can internalize finite numbers of certain partic­
ulates, e.g., Leishmania organisms [3] and zymosan [4]. In terms of 
cytokines that influence dendritic cells, granulocyte macrophage-
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epidermal dendritic cells. When explants of skin are 
placed in organ culture, dendritic cells emigrate into 
the medium for 1-3 d. The dendritic cells are mature 
and can bind tightly to small memory T cells that also 
migrate in these cultures. The emigrated mixtures of 
dendritic cells and T cells should be useful in the 
study of :many clinical states. This is illustrated by 
recent experiments showing that migratory skin cells 
are readily infected with human immunodeficiency 
virus (HIV)-1. A strong productive infection takes 
place in the absence of exogenous cytokines, foreign 
sera, or mitogens or antigens. The dendritic cell-T­
cell conjugates are the essential site for infection. 
This cellular milieu may model events during the 
sexual transmission ofHIV-1, where relevant muco­
sal surfaces are covered by skin-like epithelia. The 
capture of CD4 + memory T cells by dendritic cells 
may explain the chronic drain of immune memory in 
HIV infection. Key words: HIV-1lmemory T cellslGM­
CSFldendriti�T-cell conjugates. ] Invest Dermatol105:2S-
7S, 1995 
colony-stimulating factor (GM-CSF) can improve viability, func­
tion, and growth. Kiimpgen et al [5] found that mouse epidermal 
dendritic cells express sizable numbers of high-affinity, GM-CSF 
binding sites (3000/cell; Kd 0.5-1 nM). The cytokines interleu­
kin-I (IL-l) and tumor necrosis factor-a (TNF-a) can influence 
dendritic cells [6-8], but interestingly, macrophage-colony-stimu­
lating factor is, to date, inactive [7,9]. 
Figure 1 (lift) shows the salient features with respect to immu­
nity. Dendritic cells express high levels of accessory and antigen­
presenting molecules for T-cell stimulation [10-15]. Dendritic cells 
are specialized antigen-presenting cells (APCs): 1) dendritic cells 
are potent, as small numbers are required to elicit responses to 
antigens, superantigens, and mitogens; 2) dendritic cells activate 
quiescent T cells, including naive cells; and 3) dendritic cells are 
distributed as a system in situ, where they are effective relative to 
other APCs in capturing antigens [16-18] and in mediating both 
T-cell activation [18-20] and T-cell tolerance [21]. 
Developntent Front Proliferating Progenitors In semisolid 
cultures, mouse dendritic cells are a trace but identifiable compo­
nent of the mixed myeloid colonies (granulocytes, macrophages) 
that are induced by GM-CSF [22]. Both GM-CSF and TNFa, 
however, are required to induce colonies of human macrophages 
and dendritic cells [23]. 
In liquid culture systems, mouse and human dendritic cells can 
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Figure 1. Features of dendritic cells. The typical morphology of 
dendritic cells is diagrammed, along with markers that are useful io definiog 
dendritic cells (right) and assessing function (ltift). 
expand from proliferating progenitors in blood. liver, and bone 
marrow. The cells multiply in distinctive "balls" that attach to an 
underlying stroma (Fig 2) [24-27]. Within the ball are round cells, 
whereas around the periphery are cells that extend the character­
istic motile veils of dendritic cells. In the human system. progenitors 
lie within the CD34+ subset of cord blood and marrow [23,26,28] 
and give rise, at least in part, to progeny that are rich in Birbeck 
granules, a distinct marker for epidermal dendritic cells. To date, 
GM-CSF must be added to all culture systems that generate 
dendritic cells. Other cytokines can play significant roles. For 
example, TNF-a enhances the yield of dendritic cells from human 
CD34+ populations [23,26-29], whereas IL-4 is useful in unfrac­
tionated adult human blood [27,30]. The contribution of TNF-a 
and IL-4 may involve the suppression of other myeloid pathways of 
development, i.e., granulocytes and macrophages [27,31]. 
Maturation What emerges from the growing aggregates in 
tissue culture are nonproliferating dendritic cells with strong T­
cell-stimulatory function. However, in vivo. dendritic cells at 
intermediate stages of development likely emerge from the marrow 
(Fig 2). O'Doherty et al [32,33] identified immature dendritic cells 
in human blood. Exposure to a conditioned medium was required 
for these cells to express typical dendritic cell features (Fig 1), 
including potent T-cell-stimulatory capacity. 
The first evidence for dendritic cell "maturation" came from 
studies on isolated epidermal dendritic cells or Langerhans cells 
[34]. In culture, the dendritic cells increase in cell size and 
T-cell-stimulatory activity, and there is extensive remodeling of the 
cell surface. Major histocompatibility complex (MHC) class I and II 
products are synthesized in abundance [35-37], so that mature 
Langerhans cells can have 1-2 X 106 surface MHC II molecules 
[34]. B7, intercellular adhesion molecule-l (ICAM-l), leukocyte 
function-associated antigen-3 (LFA-3), and CD40 accessory mole­
cules are also up-regulated [10,13,38,39]. Some molecules change 
little in expression, e.g., ICAM-3, CDllb, and CD45 [10,34]. 
Others diminish. e.g., CD32 Fc'Y receptors and the F4/80 macro­
phage marker [34,40]. During the first 12 h of culture, when the 
dendritic cells actively synthesize MHC products and invariant 
chain, the cells have numerous acidic vacuoles [41] and efficiently 
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Figure 2. Development of dendritic cells. A diagram of the two broad 
stages of dendritic cell (DC) formation. a prolirerative phase and a 
maturation phase. the latter exemplified by epidermal Langerhans cells 
(LCs). 
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Figure 3. Three pools of cutaneous dendritic cells. In the steady 
state, epidermal dendritic cells seem to have a very slow turnover, as 
opposed to the sizable flux and tumover in cutaneous lymph. 
capture foreign proteins for presentation to T cells [36,42,43] . 
Then, antigen processing seems to be down-regulated, and the 
mature dendritic cells express long-lived MHC peptide complexes 
for several days. The maturation of accessory functions is illustrated 
by the presentation of a mitogenic antibody anti-CD3. Freshly 
isolated dendritic cells express substantial numbers (20,000/ cell) of 
the Fey receptors that are needed to present anti-CD3 to T cells (in 
the absence of processing), yet mature cultured dendritic cells with 
fewer than 2000 Fc'Y receptors/ cell are the active accessory cells for 
mitogenic responses [40] . 
Comparable maturation events occur in dendritic cells cultured 
from other sites. e.g., spleen [44], lung [45], heart, and kidney [46] . 
Maturation is mediated by cytokines, especially GM-CSF. The 
cytokine 'INF-a can affect dendritic cell maturation but seems to 
reduce their capacity to process and/or present proteins [30]. In vivo 
counterparts to maturation are considered below. 
Summary Cutaneous dendritic cells are part of a widespread and 
specialized system of dendritic APCs (Fig 1). Dendritic cell devel­
opment is being increasingly understood (Fig 2), as progenitors 
capable of active proliferation have been identified in marrow and 
blood. In situ, immature cells seem to exit from the marrow and 
populate tissues such as the skin. Additional exposure to cytokines, 
including GM-CSF, is needed to produce dendritic cells with their 
characteristic morphology, phenotype, and T -cell-stimulatory 
function. 
THREE POOLS OF DENDRITIC CELLS ISOLATED 
FROM SKIN 
Epidermis The properties of epidermal dendritic cells have been 
reviewed on previous occasions, including an entire volume edited 
by Schuler [47], and will not be considered here. Instead, we 
emphasize other pools of cutaneous dendritic cells that have 
received less attention (Fig 3). 
Dermis Lenz et al [48] and Nestle et al [49] isolated dendritic cells 
from the dermis. The dermal cells differ from their epidermal 
counterparts only in a lack of Birbeck granules and lower levels of 
CDla (but higher levels of CD36). The reduction in Birbeck 
granules and CDl a  may explain the failure to detect dermal 
dendritic cells heretofore in tissue sections. However, it is in culture 
that one best appreciates dendritic cells in terms of their shape and 
motility, surface phenotype by cytofluorography. and potent T­
cell-stimulating activity. 
Afferent Lymph Kelly et al [50] and Drexhage et al [51] drew 
attention to the distinctive features of the "large mononuclear 
cells" in afferent lymph. They cannulated the lymphatics in the bind 
legs of rabbits and pigs and noted cells with an unusual "veiled" 
morphology, i.e., large sheet-like processes extending in several 
directions from the cell body. Relative to macrophages , there was 
no adherence to culture surfaces, no binding of antibody-coated 
particles, and few lysosomes. Knight et al [52] then showed that 
these "veiled cells" were strong stimulators ofT cells. Comparable 
4S STEINMAN ET AL 
veiled cells were found in the mesenteric aiferent lymph that drains 
the gut of rats [53-55] and in aiferent lymphatics of the sheep limb 
[56]. In the latter instance, expression of the CDl antigen was 
prominent [57]. 
What cell is giving rise to the dendritic cells in lymph, and to 
what extent are these cells part of the pool of dendritic cells isolated 
from the dermis? In the bloodstream, potential precursors to lymph 
dendritic cells may include monocytes, which can acquire at least 
some of the features of dendritic cells when exposed to GM-CSF 
and IL-4, including CDla expression [58]. Alternatively, veiled 
cells may arise from immature dendritic cells (Fig 2), which are 
distinct from monocytes and present in blood [32,33]. These 
develop into typical dendritic cells upon exposure to cytokines. 
SUlDlDary Dendritic cells can be isolated from the epidermis, 
dermis, and aiferent lymph of skin. On the one hand, cells from 
each compartment can express all the properties that are dia­
grammed in Fig 1. On the other hand, it is possible that each pool 
of cutaneous dendritic cells will prove to have diiferences in 
function as well. An example relates to cell turnover in the steady 
state. 
TURNOVER AND FATE OF CUTANEOUS DENDRITIC 
CELLS IN THE STEADY STATE 
Epidel'Dlis The turnover of epidermal dendritic cells is slow in 
the steady state. In the first irradiation chimeras of Katz et al [59], 
marrow-derived Langerhans cells slowly replaced recipient cells 
(t1l2 of several weeks). Similar findings were made by Holt et al 
[60]. When Krueger et al [61] transplanted guinea pig or human 
skin onto nude mice, no loss of the transplanted dendritic cells 
could be detected over many months. Likewise, Chen et al [62] 
observed prolonged ('/2 year) survival of some dendritic cells in skin 
transplants. When 3H-thymidine was given to mice daily for 5 d 
and the epidermal dendritic cells were examined by autoradiogra­
phy, we could not find labeled, MHC-II-positive cells (the main 
marker used to identity epidermal dendritic cells), although many 
keratinocytes were heavily labeled (Schuler, van Furth, and Stein­
man; unpublished data). 
Del'Dlis There is no information published on the turnover of 
dermal dendritic cells. 
Afferent LylDph The considerable flux of dendritic cells in 
aiferent lymph (greater than 105 /h; reviewed in [63]) argues against 
an origin from the less abundant and the slow-turnover pool of 
epidermal Langerhans cells. Some of the lymph dendritic cells have 
Birbeck granules (3% in the study of Kelly et al [50]). Yet it is 
unlikely that most dendritic cells in lymph are epidermal derived, 
given that there are fewer than 105 dendritic cells/ cm2 of epider­
mis, and these turn over slowly (above). Therefore, the flux of 
APCs in cutaneous lymphatics far exceeds the known numbers of 
epidermal dendritic cells. Rapid turnover is also evident in mesen­
teric lymph, where most dendritic cells can be labeled in 4 -10 d 
with repeated injections of 3H-thymidine [54,64]. 
By definition, dendritic cells in aiferent lymphatics must reach the 
lymph node, but most must die there. Few are found in eiferent 
lymph. The total yield of dendritic cells from a node is about lOS. 
which is less than the number that enters lymph cannulas each day. 
In addition, dendritic cells typically are short-lived in culture, 
although GM-CSF can prolong the life span [7,9,65]. The pre­
sumed short life span of lymph dendritic cells raises the possibility 
that their exposure to cytokines in situ has been inadequate. An 
"alive" signal might occur during a successful interaction with T 
cells in the node. For example, activated helper T cells make 
GM-CSF [66] and express CD40 ligand, both of which preserve 
dendritic cell viability [67]. 
SUlDlDary Diiferent pools of dendritic cells in skin can be long 
lived, as in epidermis, or short lived, as in cutaneous aiferent lymph. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
STIMULI LEADING TO THE MOBILIZATION OF 
DENDRITIC CELLS 
Skin Transplants The long-lived pools of dendritic cells in the 
epidermis can be mobilized with specific stimuli. Larsen et al [68] 
monitored epidermal dendritic cells in transplants. Even in trans­
plants to syngeneic recipients, there is a rapid efflux of about two 
thirds of the dendritic cells into the dermis [68]. Tnere, the 
dendritic cells align in "cords," presumably because of their 
location in aiferent lymphatics. In histologic studies, the expression 
of MHC II products and B7 molecules increases markedly; i.e., 
maturation as well as migration are induced coordinately [68,69]. 
Contact Allergens Early electron microscopic studies identified 
Langerhans cells in the lymphatics of guinea pig skin treated with 
contact allergen [70], implying a movement from epidermis into 
lymph. More direct evidence for a flux of dendritic cells from skin 
to lymph node has since been reported [71-73]. Enk et al [74] 
identified criteria for maturation during contact allergy, i.e., the 
dendritic cells stained more brighdy for MHC II and expressed the 
cytokine IL-lf3. IL-lf3 may regulate some of these changes in 
epidermal Langerhans cells [74], whereas TNF-a has been impli­
cated in inducing migration to the draining node [75]. 
Skin Explant Cultures When Larsen et al [68] observed that 
epidermal dendritic cells would migrate upon transplantation, they 
tested whether migration also takes place in a simple culture system. 
When pieces of ear skin were cultured dermal-side down, dendritic 
cells emigrated in large numbers after 1 d in culture. The cells had 
the same phenotype and function as mature epidermal dendritic 
cells. These studies have been extended to human skin [11,76]. 
After a day, cells with all of the typical features of mature dendritic 
cells emigrate into the medium. It is not clear whether the cells that 
emigrate from the explants originate from long-lived pools in the 
epidermis or from the steady-state flux into aiferent lymph. Histo­
logic studies of the skin after migration do not reveal marked 
decreases in MHC-II-positive profiles in epidermis and dermis. 
SUlDlDary Situations have been identified in which cutaneous 
dendritic cells, especially those in the epidermis but possibly those 
in the dermis as well, begin to mature and migrate. These include 
skin transplantation and explantation and application of contact 
allergens. When dendritic cells bearing antigens access the draining 
lymph, these potent APCs likely enter the T-cell areas of the lymph 
node to select naive, antigen-reactive T cells from the recirculating 
repertoire. 
INTERACTIONS OF DENDRITIC CELLS WITH MEMORY 
T CELLS IN SKIN 
Delayed-Type Hypersensitivity Sites When tuberculin is in­
jected into the dermis of immune individuals, a classic influx of 
monocytes and T cells ensues. The indurated local reaction also 
contains dendritic cells with Birbeck granules [77]. The presence of 
granules does not mean that the cells are epidermal derived, 
because comparable cells can arise from CD34 + precursors in the 
absence of epidermis [26]. 
Dendritic-T-Cell Interactions in Organ Explants of Skin 
In the original studies of Larsen et al [68] with mouse skin 'explants 
(above), the other cell that was found in the emigrated population 
was the y8 T cell, the principal type of T cell in murine skin. When 
Pope et al [11] studied explants of human skin, they also noted large 
numbers of T cells. These proved to be almost entirely of the T-cell 
receptor af3 variety, the predominant type of T cell in human skin 
in situ [78]. The emigrated T cells had the same memory phenotype 
as observed in normal skin and in aiferent lymph: CD45RA low, 
CD45RO high, LFA-3/CD58 high. The T cells were not "activat­
ed," as markers such as CD25, CD80, and MHC II were expressed 
barely above background levels, and most of the cells did not 
enlarge or synthesize DNA upon subsequent culture (unless mito­
gen was added). Cutaneous T cells could form tight conjugates 
with dendritic cells [11], which resisted the shear of cell-sorting 
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Figure 4. ImmunolabeHng of con­
jugates of dendritic cells and 
memory T cells that emigrate from 
Ikin. CD3 staining shows T cells 
bound to CD3 - dendritic cells (a). 
HIV-p24 staining shows a large syncy­
tium, which fonns when conjugates are 
infected with HIV -t ( b). 
procedures. These features of cutaneous leukocytes, i.e., the pres­
ence of small memory T cells and their binding to dendritic cells, 
are easily missed in standard cutaneous suspensions, presumably 
because the suspension has an overwhelming majority of keratino­
cytes. 
What mediates dendritic cell-T-cell binding in these cultures? 
The key finding is that there is Iitde DNA synthesis even though T 
cells are tighdy bound to dendritic cells, which in tum express high 
levels of B7, ICAM, and LFA accessory molecules. Therefore, the 
binding must be independent of antigen recognition; otherwise 
T-cell receptor signaling would occur in the context of most 
known accessory molecules for T-cell activation, and there should 
be active proliferation. Instead, Pope et al [11) proposed that the 
migration and maturation of dendritic cells are triggered by explan­
tation, including the up-regulation of many molecules that have a 
measurable affinity for T cells, e.g., MHC for T-cell CD4 and CDS, 
B7 for T-cell CD2S, ICAM for LFA-l, and LFA-3 for CD2. The 
APC-T-cell interaction may become frozen, requiring antigen to 
be unlocked. Memory cells express higher levels of adhesion 
molecules as well [79). By this account, any time that a stimulus 
leads to emigration of dendritic cells in skin, some memory cells 
will be bound and captured. In the absence of antigen, the dendritic 
cell-T-cell conjugates may by default enter afferent lymph and be 
cleared in the lymph node. 
Studies on Afferent L}'IIlph Drexhage et al [51), in their first 
studies of veiled cells in cutaneous lymphatics, noted conjugates 
with small T cells. The numbers of conjugates increased when 
contact allergens were applied. Similar conjugates have been noted 
in afferent lymph from the legs of sheep [SO), dogs [SI), and people 
[S2). T cells in lymph have a memory phenotype, CD45RA1ow and 
CD45RO+ [S3,S4). These findings fit nicely with two others: T 
cells in sections of skin carry memory markers [7S], and memory 
cells bind to endothelial cells that are activated by cytokines 
[85,S6]. 
Summary Cutaneous dendritic cells contact naive T cells by 
migrating to the T-cell areas in the draining lymph node, whereas 
contacts with memory T cells, which circulate through the skin, can 
occur locally. Binding to memory T cells may occur in the absence 
of cognate antigen. The consequences of this binding are not yet 
Table I. Infection of Cutaneous Dendritic Cells and T 
Cells With HIV-l 
Mixtures of skin-derived dendritic cells and memory T cells are produc­
tively infected with HIV-l. 
Cytokines. mitogens. or foreign sera do not need to be added to the cul­
tures. 
The milieu for a productive infection is the dendritic-T-cell conjugate 
(? antigen indepeJ;ldent). 
Numerous infected syncytia fonn, and these contain both dendritic cells 
and memory CD4 + T cells. 
These events in skin-derived cells could model those occurring acutely 
during sexual transmission at mucous membranes and chronically dur­
ing the critical depletion of memory T cells. 
CUTANEOUS DENDRITIC CELLS SS 
known, except for a striking enhancement of human immunodefi­
ciency virus (HIV)-1 infection (next). 
SKIN EXPLANT CULTURE SYSTEMS TO STUDY 
CLINICAL UNKNOWNS 
Access to Dendritic Cells and T Cells in Diseased Skin 
Explant culture systems provide access to cutaneous dendritic cells 
and T cells. This could prove fruitful in the analysis of contact and 
atopic dermatitis, T-cell lymphoma, infections such as leprosy and 
Leishmaniasis, and autoimmune reactions such as psoriasis. 
A Model for Dendritic Cell Migration During Transplanta­
tion Dendritic cells migrate from grafrs to host lymphoid tissue 
[S7). This migration is usually viewed in the context of immuno­
genicity, i.e., migrating dendritic cells stimulate rejection by alert­
ing host aIIoreactive T cells in the draining lymph node that foreign 
transplantation antigens are near. 
However, Starzl et al [SS) have championed another possibility, 
that migration in the presence of immunosuppressants would lead 
to a state of microchimerism in the host, and that this could in some 
way generate tolerance. Organ culture systems might help identitY 
cytokines, pharmacologic agents, and other molecular mechanisms 
that control the maturation and migration of dendritic cells, and 
thereby influence immunogenicity and tolerance. 
An Active Site for Productive Infection With HIV-l Skin­
derived dendritic cells and T cells are sites for active productive 
infection with HIV-l [S9). When HIV-l is pulsed onto emigrated 
skin cells for 1.5 h and newly synthesized proviral DNA is 
monitored by semiquantitative polymerase chain reaction analyses 
of HIV -1 gag-containing sequences, cutaneous cells are as sensitive 
to infection with HIV-II1IB as is the standard CEM cell line. When 
the cells are cultured, without added cytokines or mitogens or 
foreign serum, a productive infection takes place. Many syncytia 
develop, and these stain for HIV-l p24 antigen (Fig 4). Productive 
infection occurred with all seven virus isolates tested, including the 
prototype macrophage (Ba-L) and T -tropic (11m) isolates. 
The permissive site in the emigrated skin cells is the dendritic­
T-cell conjugate described above. If single dendritic cells or T cells 
are sorted and exposed to HIV-l, productive infection does not 
take place. However, when the cells are mixed together, or when 
conjugates are exposed to virus, a strong infection ensues, marked 
by p24 release and syncytium formation. Both dendritic cell and 
T-cell markers are expressed on the syncytia, i.e., strong staining 
with anti-HLA-DR and anti-CD3. Some of the conclusions and 
implications of these studies are summarized in Table I. 
CONCLUSION 
We have emphasized existing information on two dynamic features 
of cutaneous dendritic cells. One is termed "maturation" and 
includes a number of events whereby dendritic cells capture 
antigens and become potent stimulators ofT-ceil-mediated immu­
nity. For example, during maturation, dendritic cells synthesize 
large amounts of MHC products and begin to express several 
accessory molecules for T-cell stimulation, such as B7-1 and B7-2, 
ICAM-l, and LFA-3. The second feature of dendritic cells, readily 
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accessible in the skin, is their capacity for "migration." Dendritic 
cells can be mobilized into the dermis and lymph to access both 
memory and naive T-cell pools, respectively. Both maturation and 
migration seem to take place when explants of skin are placed in 
organ culture. Mature, immunostimulatory dendritic cells emigrate 
into the medium along with small memory T cells. This organ 
culture system provides access to cutaneous leukocytes for studies 
of various disease processes. The latter is exemplified by the finding 
that HIV -1 generates a strong productive infection in the milieu 
that is provided by interacting cutaneous dendritic cells and mem­
ory T lymphocytes. 
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